A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis

European Heart Journal

Volumn 37, Issue 8, 2016, Pages 713-723

  Chin, Calvin W L ^a,b   Messika Zeitoun, David ^c   Shah, Anoop S V ^a   Lefevre, Guillaume ^d   Bailleul, Sophie ^d   Yeung, Emily N W ^a   Koo, Maria ^a   Mirsadraee, Saeed ^a   Mathieu, Tiffany ^c   Semple, Scott I ^a   Mills, Nicholas L ^a   Vahanian, Alec ^c   Newby, David E ^a   Dweck, Marc R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b DEPARTMENT OF CARDIOLOGY   (Singapore)

^c BICHAT HOSPITAL   (France)

^d HÔPITAL TENON   (France)

Author keywords

Aortic stenosis; cardiovascular magnetic resonance imaging; Electrocardiogram strain; high sensitivity troponin I concentrations; midwall myocardial fibrosis

Indexed keywords

TROPONIN I;

ADULT; ADVERSE OUTCOME; AGED; ANGINA PECTORIS; AORTA STENOSIS; ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL RISK SCORE; COHORT ANALYSIS; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FAINTNESS; FEMALE; FOLLOW UP; HEART MUSCLE FIBROSIS; HIGH RISK PATIENT; HUMAN; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROGNOSTIC ASSESSMENT; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; AORTA VALVE STENOSIS; CARDIAC MUSCLE; FIBROSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MORTALITY; PATHOLOGY; PROCEDURES; SURVIVAL ANALYSIS;

AGED; AORTIC VALVE STENOSIS; FEMALE; FIBROSIS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MYOCARDIUM; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 84959911917     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv525     Document Type: Article

References (23)

1. Chin CW, Vassiliou V, Jenkins WS, Prasad SK, Newby DE, Dweck MR. Markers of left ventricular decompensation in aortic stenosis. Expert Rev Cardiovasc Ther 2014; 12:901-912.
2. Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: a disease of the valve and the myocardium. J Am Coll Cardiol 2012;60:1854-1863.
3. Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V, Bauer EP, Klovekorn WP, Schaper J. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart structural deterioration and compensatory mechanisms. Circulation 2003;107:984-991.
4. Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G, BanyaW, Gulati A, Roussin I, Raza S, Prasad NA, Wage R, Quarto C, Angeloni E, Refice S, Sheppard M, Cook SA, Kilner PJ, Pennell DJ, Newby DE, Mohiaddin RH, Pepper J, Prasad SK. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol 2011;58:1271-1279.
5. Weidemann F, Herrmann S, Stö rk S, Niemann M, Frantz S, Lange V, Beer M, Gattenlohner S, Vö elker W, Erti G, Strotmann JM. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 2009;120:577-584.
6. Quarto C, Dweck MR, Murigu T, Joshi S, Melina G, Angeloni E, Prasad SK, Pepper JR. Late gadolinium enhancement as a potential marker of increased perioperative risk in aortic valve replacement. Interact Cardiovasc Thorac Surg 2012;15: 45-50.
7. Azevedo CF, Nigri M, Higuchi ML, Pomerantzeff PM, Spina GS, Sampaio RO, Tarasoutchi F, Grinberg M, Rochitte CE. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol 2010;56:278-287.
8. Milano AD, Faggian G, Dodonov M, Golia G, Tomezzoli A, Bortolotti U, Mazzucco A. Prognostic value of myocardial fibrosis in patients with severe aortic valve stenosis. J Thorac Cardiovasc Surg 2010;144:830-837.
9. Barone-Rochette G, Piérard S, De Meester de Ravenstein C, Seldrum S, Melchior J, Maes F, Pouleur AC, Vancraeynest D, Pasquet A, Vanoverschelde JL, Gerber BL. Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement. J Am Coll Cardiol 2014;64:144-154.
10. Chin CW, Shah AS, McAllister DA, Joanna Cowell S, Alam S, Langrish JP, Strachan FE, Hunter AL, Maria Choy A, Lang CC, Walker S, Boon NA, Newby DE, Mills NL, Dweck MR. High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis. Eur Heart J 2014;35:2312-2321.
11. Shah AS, ChinCW, Vassiliou V, Cowell SJ, Doris M, Kwok TC, Semple S, Zamvar V, White AC, McKillop G, Boon NA, Prasad SK, Mills NL, Newby DE, Dweck MR. Left ventricular hypertrophy with strain and aortic stenosis. Circulation 2014;130: 1607-1616.
12. Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, Boon NA. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2389-2397.
13. Romhilt DW, Estes EH. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 1968;75:752-758.
14. HancockEW, Deal BJ, Mirvis DM, Okin P, Kligfield P, Gettes LS, Bailey JJ, Childers R, Gorgels A, Josephson M, Kors JA, Macfarlene P, Mason JW, Pahlm O, Rautaharju PM, Surawicz B, van Herpen G, Wagner GS, Wellens H. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram. J Am Coll Cardiol 2009;53:992-1002.
15. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinoñes M. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009; 22:1-23.
16. Krintus M, Kozinski M, Boudry P, Capell NE, Kö ller U, Lackner K, Lefèvre G, Lennartz L, Lotz J, Herranz AM, Nybo M, Plebani M, Sandberg MB, Schratzberger W, Shih J, Skadberg ∅, Chargui AT, Zaninotto M, Sypniewska G. European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay. Clin Chem Lab Med 2014;52:1657-1665.
17. Triage BNP [Package Insert]. 2007. http://www.cliawaived.com/web/items/pdf/Triage-BNP-product-insert~1566file1.pdf (1 February 2015).
18. Roche NT-pro BNP assay [Package Insert]. 2006. http://www.rochecanada.com/content/dam/internet/corporate/rochecanada/en-CA/documents/package-inserts/ProBNPII-04842464190-EN-V9-CAN.pdf (1 February 2015).
19. The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012;33:2451-2496.
20. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM III, Thomas JD, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Creager MA, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Stevenson WG, Yancy CW. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:e57-e185.
21. Kupari M, Turto H, Lommi J. Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure? Eur Heart J 2005; 26:1790-1796.
22. Seiler C, Jenni R. Severe aortic stenosis without left ventricular hypertrophy: prevalence, predictors, and short-term follow up after aortic valve replacement. Heart 1996;76:250-255.
23. Dweck MR, Joshi S, Murigu T, Gulati A, Alpendurada F, Jabbour A, Maceira A, Roussin I, Northridge DB, Kilner PJ, Cook SA, Boon NA, Pepper J, Mohiaddin RH, Newby DE, Pennell DJ, Prasad SK. Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012;14:50.